Pathological gambling: A review of phenomenological models and treatment modalities for an underrecognized psychiatric disorder

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 8, Issue 6, 2006, Pages 334-339

  Dannon, Pinhas N ^a,b   Lowengrub, Katherine ^a   Gonopolski, Yehudit ^a   Musin, Ernest ^a   Kotler, Moshe ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Rehovot Community Mental Health and Rehabilitation Clinic   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ESCITALOPRAM; FLUVOXAMINE; LITHIUM CARBONATE; NALMEFENE; NALTREXONE; NEFAZODONE; PAROXETINE; PLACEBO; SERTRALINE; TOPIRAMATE; VALPROIC ACID;

ADDICTION; BIPOLAR DISORDER; CLINICAL TRIAL; COGNITIVE THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG MECHANISM; EATING DISORDER; GENETIC PREDISPOSITION; HIGH RISK BEHAVIOR; HUMAN; IMPULSIVENESS; MONOTHERAPY; OBSESSIVE COMPULSIVE DISORDER; OFF LABEL DRUG USE; PATHOLOGICAL GAMBLING; PREVALENCE; PSYCHOTHERAPY; PSYCHOTRAUMA; REVIEW; SEX DIFFERENCE; STRESS; SUBSTANCE ABUSE;

EID: 33845690834     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.v08n0603     Document Type: Review

References (64)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
2. World Health Organization. International Classification of Diseases, Tenth Revision. Geneva, Switzerland: World Health Organization; 1992
3. Shaffer HJ, Hall MN, Vander Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health 1999;89:1369-1376
4. Hollander E, Buchalter AJ, DeCaria CM. Pathological gambling. Psychiatr Clin North Am 2000;23:629-642
5. Morasco BJ, Vom Eigen KA, Petry NM. Severity of gambling is associated with physical and emotional health in urban primary care patients. Gen Hosp Psychiatry 2006;28:94-100
6. Weinstock J, Blanco C, Petry NM. Health correlates of pathological gambling in a methadone maintenance clinic. Exp Clin Psychopharmacol 2006;14:87-93
7. Milton S, Crino R, Hunt C, et al. The effect of compliance-improving interventions on the cognitive-behavioural treatment of pathological gambling. J Gambl Stud 2002;18:207-229
8. Shah KR, Eisen SA, Xian H, et al. Genetic studies of pathological gambling: a review of methodology and analyses of data from the Vietnam era twin registry. J Gambl Stud 2005;21:179-203
9. Black DW, Monahan PO, Temkit M, et al. A family study of pathological gambling. Psychiatry Res 2006;141:295-303
10. Blanco C, Moreyra P, Nunes EV, et al. Pathological gambling: addiction or compulsion? Semin Clin Neuropsychiatry 2001;6:167-176
11. Grant JE, Kim SW. Comorbidity of impulse control disorders in pathological gamblers. Acta Psychiatr Scand 2003;108:203-207
12. Sood ED, Pallanti S, Hollander E. Diagnosis and treatment of pathologic gambling. Curr Psychiatry Rep 2003;5:9-15
13. Dell'Osso B, Hollander E. The impact of comorbidity on the management of pathological gambling. CNS Spectr 2005;10:619-621
14. Dell'Osso B, Allen A, Hollander E. Comorbidity issues in the pharmacological treatment of pathological gambling: a critical review. Clin Pract Epidemol Ment Health 2005;1:21
15. Grant JE, Levine L, Kim D, et al. Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 2005;162:2184-2188
16. Slutske WS. Natural recovery and treatment-seeking in pathological gambling: results of two US national surveys. Am J Psychiatry 2006;163:297-302
17. Hollander E, Wong CM. Obsessive-compulsive spectrum disorders. J Clin Psychiatry 1995;56(suppl 4):3-6; discussion 53-55
18. Chambers RA, Potenza MN. Neurodevelopment, impulsivity, and adolescent gambling. J Gambl Stud 2003;19:53-84
19. Bechara A. Risky business: emotion, decision-making, and addiction. J Gambl Stud 2003;19:23-51
20. Bechara A, Damasio H. Decision-making and addiction, pt 1: impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia 2002;40:1675-1689
21. Bechara A, Dolan S, Hindes A. Decision-making and addiction, pt 2: myopia for the future or hypersensitivity to reward? Neuropsychologia 2002;40:1690-1705
22. Dannon PN, Lowengrub K, Sasson M, et al. Comorbid psychiatric diagnoses in kleptomania and pathological gambling: a preliminary comparison study. Eur Psychiatry 2004;19:299-302
23. Dannon PN, Lowengrub K, Aizer A, et al. Pathological gambling: comorbid psychiatric diagnoses in patients and their families. Isr J Psychiatry Relat Sci 2006;43:88-92
24. Dannon PN, Lowengrub K, Gonopolski Y, et al. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol 2005;28:6-10
25. Dannon PN, Lowengrub K, Musin E, et al. Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study. J Clin Psychopharmacol 2005;25:593-596
26. Dannon PN, Lowengrub K, Musin E, et al. Sustained release bupropion in the treatment of SSRI nonresponder pathological gamblers: pilot study and review of the literature. Therapy 2005;2:753-759
27. Kertzman S, Lowengrub K, Aizer A, et al. Stroop performance in pathological gamblers. Psychiatry Res 2006;142:1-10
28. Dannon PN, Lowengrub K, Shalgi B, et al. Dual psychiatric diagnoses and substance abuse in pathological gamblers: a preliminary gender comparison study. J Addict Dis 2006;25:49-54
29. Lynch WJ, Maciejewski PK, Potenza MN. Psychiatric correlates of gambling in adolescents and young adults grouped by age at gambling onset. Arch Gen Psychiatry 2004;61:1116-1122
30. Vachon J, Vitaro F, Wanner B, et al. Adolescent gambling: relationships with parent gambling and parenting practices. Psychol Addict Behav 2004;18:398-401
31. Steel Z, Blaszczynski A. Impulsivity, personality disorders and pathological gambling severity. Addiction 1998;93:895-905
32. Spinella M. Evolutionary mismatch, neural reward circuits, and pathological gambling. Int J Neurosci 2003;113:503-512
33. Black DW. An open-label trial of bupropion in the treatment of pathological gambling. J Clin Psychopharmacol 2004;24:108-110
34. Pallanti S, Quercioli L, Sood E, et al. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiatry 2002;63:559-564
35. Blanco C, Hasin DS, Petry N, et al. Sex differences in subclinical and DSM-IV pathological gambling: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 2006;36:943-953
36. Desai RA, Maciejewski PK, Pantalon MV, et al. Gender differences in adolescent gambling. Ann Clin Psychiatry 2005;17:249-258
37. Blaszczynski A. Pathological gambling and obsessive-compulsive spectrum disorders. Psychol Rep 1999;84:107-113
38. Potenza MN, Fiellin DA, Heninger GR, et al. Gambling: an addictive behavior with health and primary care implications. J Gen Intern Med 2002;17:721-732
39. Petry NM. How treatments for pathological gambling can be informed by treatments for substance use disorders. Exp Clin Psychopharmacol 2002;10:184-192
40. Goudriaan AE, Oosterlaan J, de Beurs E, et al. Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction 2006;101:534-547
41. Sylvain C, Ladouceur R, Boisvert JM. Cognitive and behavioral treatment of pathological gambling: a controlled study. J Consult Clin Psychol 1997;65:727-732
42. Echeburua E, Baez C, Fernandez-Montalvo J. Comparative effectiveness of three therapeutic modalities in the psychological treatment of pathological gambling. Behav Cog Psychother 1996;24:51-72
43. Echeburua E, Fernandez-Montalvo J, Baez C. Prevention in the treatment of slot-machine pathological gambling: long-term outcome. Behav Ther 2000;31:351-364
44. McCusker CG. Cognitive biases and addiction: an evolution in theory and method. Addiction 2001;96:47-56
45. Toneatto T. Cognitive psychopathology of problem gambling. Subst Use Misuse 1999;34:1593-1604
46. Petry NM, Roll JM. A behavioral approach to understanding and treating pathological gambling. Semin Clin Neuropsychiatry 2001;6:177-183
47. Kausch O, Rugle L, Rowland DY. Lifetime histories of trauma among pathological gamblers. Am J Addict 2006;15:35-43
48. Waska R. Addictions and the quest to control the object. Am J Psychoanal 2006;66:43-62
49. Hollander E, DeCaria CM, Finkell JN, et al. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol Psychiatry 2000;47:813-817
50. Blanco C, Petkova E, Ibanez A, et al. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 2002;14:9-15
51. Kim SW, Grant JE, Adson DE, et al. A double-blind, placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.J Clin Psychiatry 2002;63:501-507
52. Grant JE, Kim SW, Potenza MN, et al. Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int Clin Psychopharmacol 2003;18:243-249
53. Saiz-Ruiz J, Blanco C, Ibanez A, et al. Sertraline treatment of pathological gambling: a pilot study. J Clin Psychiatry 2005;66:28-33
54. Grant JE, Potenza MN. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. Int Clin Psychopharmacol 2006;21:203-209
55. Pallanti S, Baldini Rossi N, Sood E, et al. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial. J Clin Psychiatry 2002;63:1034-1039
56. Coccaro EF, Kavoussi RJ, Sheline YI, et al. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Arch Gen Psychiatry 1996;53:531-536
57. Hollander E, Pallanti S, Allen A, et al. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry 2005;162:137-145
58. Hollister LE, Schwin RL, Kasper P. Naltrexone treatment of opiate-dependent persons. Drug Alcohol Depend 1977;2:203-209
59. Anton RF. Pharmacologic approaches to the management of alcoholism. J Clin Psychiatry 2001;62(suppl 20):11-17
60. Kim SW, Grant JE, Adson DE, et al. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001;49:914-921
61. Grant JE, Potenza MN, Hollander E, et al. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 2006;163:303-312
62. Kim SW, Grant JE, Yoon G, et al. Safety of high-dose naltrexone treatment: hepatic transaminase profiles among outpatients. Clin Neuropharmacol 2006;29:77-79
63. Zwar N, Richmond R. Bupropion sustained release: a therapeutic review of Zyban. Aust Fam Physician 2002;31:443-447
64. Welte JW, Wieczorek WF, Barnes GM, et al. The relationship of ecological and geographic factors to gambling behavior and pathology. J Gambl Stud 2004;20:405-410